As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval ...

18 February 2024 While President Biden’s desire to reduce costs at the pharmacy counter is commendable, it is too blunt an ...

A US biopharma firm must pay the damages to Sandoz over a long-running dispute over lung therapy | New Jersey district judge ...

A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | ...

Startup CFO’s betrayal is a lesson in preparing for the worst ...

Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

New hire specialises in guiding life sciences and health tech clients through compliance issues | Work includes US regulations, including those enforced by the FDA, Drug Enforcement Administration and ...

The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s potential, says Graeme Moore of Mewburn Ellis.